{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:27:47Z","timestamp":1762928867368,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jceh.2020.12.006","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T02:28:22Z","timestamp":1609381702000},"page":"484-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?"],"prefix":"10.1016","volume":"11","author":[{"given":"Praveen","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShriHari","family":"Anikhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khare","family":"Shivam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2020.12.006_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A\u00a0novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2020.12.006_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2020.12.006_bib3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2020.12.006_bib4","first-page":"m792","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2020.12.006_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2020.12.006_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jceh.2020.12.006_bib7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/liv.14455","article-title":"Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2020.12.006_bib8","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/gerona\/glaa089","article-title":"Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study","volume":"75","author":"Chen","year":"2020","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jceh.2020.12.006_bib9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical features of COVID-19-related liver damage","volume":"18","author":"Fan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib10","article-title":"Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-existing Liver Disease in United States: A Multi-Center Research Network Study","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.12.006_bib11","first-page":"433","article-title":"Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study","volume":"70","author":"Qi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.12.006_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2020.05.013","article-title":"High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry","volume":"73","author":"Moon","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2020.12.006_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2020.12.006_bib14","first-page":"1","article-title":"Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids","author":"Zhao","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.jceh.2020.12.006_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jceh.2020.12.006_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: abnormal liver function tests","volume":"73","author":"Cai","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib17","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/liv.14465","article-title":"Coronavirus disease 2019 and prevalence of chronic liver disease: a meta-analysis","volume":"40","author":"Mantovani","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2020.12.006_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MEG.0000000000001742","article-title":"Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis","volume":"33","author":"Lippi","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib19","first-page":"1","article-title":"Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort","volume":"0","author":"Bajaj","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.12.006_bib20","first-page":"1","article-title":"Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; the APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)","author":"Sarin","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.12.006_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.31301","article-title":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China","volume":"72","author":"Lei","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.12.006_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/cld.974","article-title":"Chronic liver disease and COVID-19: alcohol use disorder\/alcohol-associated liver disease, nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis, autoimmune liver disease, and compensated cirrhosis","volume":"15","author":"Kushner","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2020.12.006_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2020.12.006_bib25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study","volume":"73","author":"Ji","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib26","doi-asserted-by":"crossref","first-page":"154244","DOI":"10.1016\/j.metabol.2020.154244","article-title":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","volume":"19","author":"Zheng","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2020.12.006_bib27","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.12.006_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jgh.15112","article-title":"Pan KHet al Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients","volume":"36","author":"Gao","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2020.04.027","article-title":"Younger patients with MAFLD are at increased risk of severe COVID-19 illness: a multicenter preliminary analysis","volume":"73","author":"Zhou","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib30","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep4.1557","article-title":"Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients","volume":"4","author":"Gerussi","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2020.12.006_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hep.31281","article-title":"Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement","volume":"72","author":"Fix","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.12.006_bib32","article-title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2020.12.006_bib33","first-page":"1","article-title":"Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations","author":"Lau","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.12.006_bib34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S2468-1253(20)30080-7","article-title":"Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis","volume":"5","author":"Xiao","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib35","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/liv.14506","article-title":"Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"40","author":"Qiu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2020.12.006_bib36","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2020.12.006_bib37","article-title":"Management of hepatocellular carcinoma during the COVID-19 pandemic \u2013 s\u00e3o paulo Cl\u0131'nicas liver cancer group multidisciplinary consensus statement","volume":"26","author":"Chagas","year":"2020","journal-title":"Clinics"},{"key":"10.1016\/j.jceh.2020.12.006_bib38","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/gutjnl-2020-321923","article-title":"COVID-19 in an international European liver transplant recipient cohort","volume":"69","author":"Becchetti","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.12.006_bib39","first-page":"404","article-title":"The impact of COVID-19 global pandemic on morbidity and mortality of liver transplant recipients children and adults: a systematic review of case series","volume":"12","author":"Gavriilidis","year":"2020","journal-title":"J\u00a0Clin Med Res"},{"key":"10.1016\/j.jceh.2020.12.006_bib40","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/tri.13680","article-title":"Share impact of COVID-19 on liver transplantation in europe: alert from an early survey of European liver and intestine transplantation association (ELITA) and European liver transplant registry (ELTR)","volume":"33","author":"Polak","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2020.12.006_bib41","doi-asserted-by":"crossref","first-page":"13372","DOI":"10.1111\/tid.13372","article-title":"Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: initial experience at a single center in Madrid, Spain","volume":"22","author":"Loinaz","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jceh.2020.12.006_bib42","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S2468-1253(20)30116-3","article-title":"COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy","volume":"5","author":"Bhoori","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.12.006_bib43","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/liv.14516","article-title":"First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19","volume":"40","author":"Muhovi\u0107","year":"2020","journal-title":"Liver Int"},{"year":"2020","series-title":"Repurposed antiviral drugs for COVID-19\u2013interim WHO solidarity trial results","author":"Pan","key":"10.1016\/j.jceh.2020.12.006_bib44"},{"key":"10.1016\/j.jceh.2020.12.006_bib45","doi-asserted-by":"crossref","first-page":"101-106","DOI":"10.1258\/jtt.2012.120612","article-title":"Successful treatment of patients with hepatitis C in rural and remote Western Australia via telehealth","volume":"19","author":"Nazareth","year":"2013","journal-title":"J\u00a0Telemed Telecare"},{"key":"10.1016\/j.jceh.2020.12.006_bib46","doi-asserted-by":"crossref","first-page":"674-675","DOI":"10.1001\/jamasurg.2015.0676","article-title":"Using telehealth to enable patient-centered care for liver transplantation","volume":"150","author":"Ertel","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jceh.2020.12.006_bib47","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1007\/s10620-015-3744-3","article-title":"An automated telephone monitoring system to identify patients with cirrhosis at risk of re-hospitalization","volume":"60","author":"Thomson","year":"2015","journal-title":"Dig Dis Sci"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320301869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320301869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:06:46Z","timestamp":1760854006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688320301869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0973688320301869"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2020.12.006","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2020.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}